Equities

Shenzhen Chipscreen Biosciences Co Ltd

688321:SHH

Shenzhen Chipscreen Biosciences Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)15.82
  • Today's Change-0.04 / -0.25%
  • Shares traded1.55m
  • 1 Year change-29.91%
  • Beta1.2232
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments845981382
Total Receivables, Net224168130
Total Inventory472815
Prepaid expenses9.346.169.36
Other current assets, total4.52--102
Total current assets1,1301,184639
Property, plant & equipment, net1,0721,115816
Goodwill, net------
Intangibles, net583467356
Long term investments3897433
Note receivable - long term------
Other long term assets222623
Total assets3,2032,8961,894
LIABILITIES
Accounts payable8.980.322.23
Accrued expenses835145
Notes payable/short-term debt130186120
Current portion long-term debt/capital leases392323
Other current liabilities, total129281104
Total current liabilities391541294
Total long term debt9095996.30
Total debt1,078808149
Deferred income tax23----
Minority interest060--
Other liabilities, total170180177
Total liabilities1,4931,380477
SHAREHOLDERS EQUITY
Common stock411411411
Additional paid-in capital1,1381,0751,125
Retained earnings (accumulated deficit)1435437
Treasury stock - common(113)(155)(155)
Unrealized gain (loss)------
Other equity, total131130(0.29)
Total equity1,7101,5151,418
Total liabilities & shareholders' equity3,2032,8961,894
Total common shares outstanding408407407
Treasury shares - common primary issue3.753.753.75
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.